Investors / filer profile

Telman Deborah H

EVP, Corporate Affairs & GC

active in 2 companies

Pro
Bought: Pro
Sold: 16
Filings: 2
Companies: 2026-05-18
Last filed

EDGAR · CIK 0001860008 ↗

Track record

How each disclosed position did against the S&P ~6 months later

No positions we can measure against the market yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$0.0000 bought · −$6.59M sold

All filings on record

Every Form 4 transaction we track for this filer


ATRCAtriCure, Inc.	Grant — · 6,144 sh	2026-05-18	—
GILDGILEAD SCIENCES, INC.	Sell $61.5K · 500 sh	2025-11-12	—
GILDGILEAD SCIENCES, INC.	Exercise $30.4K · 500 sh	2025-11-12	—
GILDGILEAD SCIENCES, INC.	Sell $4.40M · 35,965 sh	2025-11-12	—
GILDGILEAD SCIENCES, INC.	Exercise $2.18M · 35,965 sh	2025-11-12	—
GILDGILEAD SCIENCES, INC.	Sell $2.13M · 17,181 sh	2025-11-12	—
GILDGILEAD SCIENCES, INC.	Exercise $1.29M · 17,181 sh	2025-11-12	—
GILDGILEAD SCIENCES, INC.	Tax $29.1K · 241 sh	2025-10-25	—
GILDGILEAD SCIENCES, INC.	Exercise — · 515 sh	2025-10-25	—
GILDGILEAD SCIENCES, INC.	Tax $73.1K · 634 sh	2025-09-10	—

ATRCGrant

2026-05-18 · AtriCure, Inc.

6,144

—

GILDSell

2025-11-12 · GILEAD SCIENCES, INC.

$61.5K

—

GILDExercise

2025-11-12 · GILEAD SCIENCES, INC.

$30.4K

—

GILDSell

2025-11-12 · GILEAD SCIENCES, INC.

$4.40M

—

GILDExercise

2025-11-12 · GILEAD SCIENCES, INC.

$2.18M

—

GILDSell

2025-11-12 · GILEAD SCIENCES, INC.

$2.13M

—

GILDExercise

2025-11-12 · GILEAD SCIENCES, INC.

$1.29M

—

2025-10-25 · GILEAD SCIENCES, INC.

$29.1K

—

GILDExercise

2025-10-25 · GILEAD SCIENCES, INC.

515

—

2025-09-10 · GILEAD SCIENCES, INC.

$73.1K

—

Newest 10 of 16 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.